Catalysts for Sumitomo Pharma America Inc
7 tracked
Feb 24, 2026
approval
LURASIDONE HYDROCHLORIDE — FDA approval
Sumitomo Pharma America Inc
→
Feb 24, 2026
approval
LURASIDONE HYDROCHLORIDE — FDA approval
Sumitomo Pharma America Inc
→
Oct 8, 2025
approval
ORGOVYX (RELUGOLIX) — FDA approval
relugolix
→
Oct 18, 2024
approval
ORGOVYX (RELUGOLIX) — FDA approval
relugolix
→
Mar 30, 2023
approval
ORGOVYX (RELUGOLIX) — FDA approval
relugolix
→
Dec 28, 2020
approval
LURASIDONE HYDROCHLORIDE — FDA approval
Sumitomo Pharma America Inc
→
Dec 18, 2020
approval
ORGOVYX (RELUGOLIX) — FDA approval
relugolix
→